Dexamethasone May Hinder Immunotherapy for Glioblastoma
Findings seen in preclinical studies of mice, survival data from patients receiving PD-(L)1 blockade for GBM
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.